Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) · children undergoing neurodiagnostic procedures
1 finding from 1 review
Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' · women with endometriosis
2 findings from 1 review
Self‐reported pain: menstrual pain reduction from baseline to end of treatment · women with endometriosis
1 finding from 1 review
Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' · women with endometriosis
2 findings from 1 review
Self‐reported pain (dysmenorrhoea) (dichotomous data) ‐ reduction of pain to zero at 6 months' · women with endometriosis
It is very uncertain whether combined oral contraceptive pill changes self‐reported pain (dysmenorrhoea) (dichotomous data): reduction of… compared with other medical treatment (very low certainty).
2 findings from 1 review
Live birth or ongoing pregnancy · women undergoing assisted reproduction
Combined oral contraceptive pill probably leads to lower live birth or ongoing pregnancy (COCP + Ant vs Ant) compared with no pretreatment (moderate certainty).
2 findings from 1 review
Pregnancy loss · women undergoing assisted reproduction
Combined oral contraceptive pill showed no clear difference in pregnancy loss (COCP + Ant vs Ant) compared with no pretreatment (moderate certainty).
2 findings from 1 review
Multiple pregnancy rate · women undergoing assisted reproduction
Combined oral contraceptive pill showed no clear difference in multiple pregnancy rate (COCP + Ant vs Ant) compared with no pretreatment (low certainty).
2 findings from 1 review
OHSS · women undergoing assisted reproduction
Combined oral contraceptive pill showed no clear difference in OHSS rate (COCP + Ant vs Ant) compared with no pretreatment (low certainty).
2 findings from 1 review
Change in weight (kg) · children with chronic disease
1 finding from 1 review
Change in weight z score · children with chronic disease
1 finding from 1 review
Change in height · children with chronic disease
1 finding from 1 review
Change in BMI · children with chronic disease
1 finding from 1 review
Change in total calories (Kcal/day): at 12 months · children with chronic disease
1 finding from 1 review
Change in total protein intake (g/day) at 3 months · children with chronic disease
1 finding from 1 review
FEV1 · children with chronic disease
1 finding from 1 review
Death (all causes) · people with CKD
Patient‐centred outcomes for oral showed no clear difference in death (all causes) compared with IV iron (low certainty).
1 finding from 1 review
Cardiovascular mortality · people with CKD
It is very uncertain whether patient‐centred outcomes for oral changes cardiovascular death compared with IV iron (very low certainty).
1 finding from 1 review
Type of adverse event: allergic reactions/hypotension · people with CKD
Patient‐centred outcomes for oral may leads to higher type of adverse event: allergic reactions/hypotension compared with IV iron (low certainty).
1 finding from 1 review
Gastrointestinal effects · people with CKD
Patient‐centred outcomes for oral may leads to lower type of adverse event: all gastrointestinal adverse effects compared with IV iron (low certainty).
1 finding from 1 review